139
Views
0
CrossRef citations to date
0
Altmetric
Immunology

The economic impact of suboptimal treatment and treatment switch among patients with Crohn’s disease treated with a first-line biologic – A US retrospective claims database study

, , , , , , , & show all
Pages 931-940 | Received 12 Apr 2024, Accepted 27 Jun 2024, Published online: 16 Jul 2024